US Patent Granted to RBC Life Sciences, Inc. for Supplement that Supports Cognitive Function

IRVING, Texas, Jan. 30, 2013 /PRNewswire/ -- RBC Life Sciences, Inc. (OTCQB: RBCL) (the "Company"), has been granted US Patent 8357422, which protects its unique dietary supplement formulation that nutritionally supports cognitive function, learning and remembering. The Company markets this supplement under the name "Neurobright^®." The grant of this patent evidences the Company's continued commitment to bring effective science-based dietary supplements to the market.

"The basis for the patent was an 18-month controlled animal study conducted by Dr. Tres Thompson of the School of Behavioral and Brain Sciences at the University of Texas at Dallas," said Clinton Howard, CEO. "The study showed that Neurobright increased both cognitive function and psychomotor abilities in animals."

Dr. Thompson presented the report on this study at the 2008 annual conference of the Society for Neuroscience. The report stated, "Neurobright enabled aging animals to have memory and learning function like younger animals." In describing his observations from the study, Dr. Thompson said, "Some prescription drugs will improve cognitive function, but not once in my 25-year tenure, have test subjects improved so dramatically from a safe and natural product."

In addition to improved cognitive function, the animals that received Neurobright lived longer than the control animals that were not given Neurobright.

About RBC Life Sciences

Through wholly owned subsidiaries, RBC Life Sciences develops, markets and distributes high-quality nutritional supplements and personal care products under its RBC Life brand to a growing population of consumers seeking wellness and a healthy lifestyle. Through its wholly owned subsidiary, MPM Medical, the Company also develops and markets to health care professionals in the United States proprietary prescription and nonprescription products for advanced wound care and pain management. All products are tested for quality assurance in-house, and by outside independent laboratories, to comply with regulations in the U.S. and in more than thirty countries in which the products are distributed. For more information, visit the company's website at www.rbclifesciences.com.

The statements above, other than statements of historical fact, may be forward-looking. Actual events will be dependent upon a number of factors and risks including, but not limited to, changes in plans by the Company's management, delays or problems in production, changes in the regulatory process, changes in market trends, and a number of other factors and risks described from time to time in the Company's filings with the Securities and Exchange Commission.

For Further Information:
Richard S. Jablonski, VP, CFO

Tel: 972-893-4000
rick.jablonski@rbclifesciences.com

SOURCE RBC Life Sciences, Inc.